title: Pharmacokinetics and distribution of ketamine after extradural administration to dogs.
abstract: We have studied the pharmacokinetics and distribution of ketamine and its biotransformation products in dogs after extradural administration of ketamine at L4-5. The mean apparent uptake rate constants of ketamine for plasma and CSF were 4.17 (SD 1.84) and 5.15 (2.50) h-1, respectively. The concentrations of ketamine in CSF were greater than those found in plasma. The elimination half-life values of the parent drug for both biological fluids were similar (4.3 (2.96) h and 4.6 (3.31) h for plasma and CSF, respectively). The apparent formation rate constant of norketamine was greater than that of dehydronorketamine. However, the concentrations of the biotransformation products in CSF were smaller than those of the parent drug. These results are similar to the distribution of ketamine and its metabolites in different cerebral structures and tissues. The concentrations decreased in concert with the increase in polarity of the metabolites. A specific distribution for all compounds was observed. Ketamine showed a greater affinity for brainstem, while norketamine and dehydronorketamine were distributed mostly in cerebellum and kidney, respectively.
authors.affiliation: Department of Pharmacy, Faculty of Pharmacy, University of Salamanca, Spain.
authors.forename: J L
authors.initials: JL
authors.lastname: Pedraz
authors.forename: M B
authors.initials: MB
authors.lastname: Calvo
authors.forename: A R
authors.initials: AR
authors.lastname: Gascon
authors.forename: R
authors.initials: R
authors.lastname: Hernandez
authors.forename: C
authors.initials: C
authors.lastname: Muriel
authors.forename: L M
authors.initials: LM
authors.lastname: Torres
authors.forename: A
authors.initials: A
authors.lastname: Dominguez-Gil
mesh_terms: D000767:Anesthesia, Epidural; D000768:Anesthesia, General; D000818:Animals; D001711:Biotransformation; D001921:Brain / Q000378:metabolism; D004285:Dogs; D005260:Female; D006207:Half-Life; D007649:Ketamine / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics*; D008297:Male
chemical_list: C033420:5,6-dehydronorketamine; D007649:Ketamine; C033419:norketamine